Control of RSV-induced lung injury by alternatively activated macrophages is IL-4Rα-, TLR4-, and IFN-β-dependent

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Mucosal Immunology

• Publication date

  2010-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/mi.2010.6PMID 20404812PMCID PMC2875872
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Correction: Immunologic Consequences of Francisella tularensis Live Vaccine Strain Infection: Role of the Innate Immune Response in Infection and Immunity

  2021cited by this paper
• References Subscriptions Permissions Email Alerts Respiratory Syncytial Virus (RSV) Infection Induces Cyclooxygenase 2: A Potential Target for RSV Therapy

  2013cited by this paper
• Alternative activation of macrophages: mechanism and functions.

  2010cited by this paper
• Alternative activation of macrophages: immune function and cellular biology.

  2009cited by this paper
• Alternatively activated macrophages participate in the recruitment of eosinophils to the lung in a murine model of allergic lung inflammation (79.2)

  2009cited by this paper
• Deletion of PPARγ in Alveolar Macrophages Is Associated with a Th-1 Pulmonary Inflammatory Response1

  2009cited by this paper
• STAT1 Negatively Regulates Lung Basophil IL-4 Expression Induced by Respiratory Syncytial Virus Infection1

  2009cited by this paper
• Toll-like receptor–induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens

  2008cited by this paper
• Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease

  2008cited by this paper
• Francisella tularensis Live Vaccine Strain Induces Macrophage Alternative Activation as a Survival Mechanism1

  2008cited by this paper
• Identification of Oxidative Stress and Toll-like Receptor 4 Signaling as a Key Pathway of Acute Lung Injury

  2008cited by this paper
• Peroxisome Proliferator-activated Receptor γ Activation Promotes Infiltration of Alternatively Activated Macrophages into Adipose Tissue*

  2008cited by this paper
• Sustained desensitization to bacterial Toll-like receptor ligands after resolutionof respiratory influenza infection

  2008cited by this paper
• Alveolar Macrophages Are a Major Determinant of Early Responses to Viral Lung Infection but Do Not Influence Subsequent Disease Development

  2008cited by this paper
• Respiratory Syncytial Virus Activates Innate Immunity through Toll-Like Receptor 2

  2008cited by this paper
• Host immunity during RSV pathogenesis.

  2008cited by this paper
• Cutting Edge: Involvement of the Type I IFN Production and Signaling Pathway in Lipopolysaccharide-Induced IL-10 Production1

  2007cited by this paper
• Macrophage-specific PPARγ controls alternative activation and improves insulin resistance

  2007cited by this paper
• Protective immune mechanisms in helminth infection

  2007cited by this paper
• Respiratory Syncytial Virus Infects and Abortively Replicates in the Lungs in Spite of Preexisting Immunity

  2007cited by this paper
• Interferon-Inducible Mx Gene Expression in Cotton Rats: Cloning, Characterization, and Expression During Influenza Viral Infection

  2006cited by this paper
• Retinoic Acid-Inducible Gene I Mediates Early Antiviral Response and Toll-Like Receptor 3 Expression in Respiratory Syncytial Virus-Infected Airway Epithelial Cells

  2006cited by this paper
• The TLR4 agonist, monophosphoryl lipid A, attenuates the cytokine storm associated with respiratory syncytial virus vaccine-enhanced disease.

  2006cited by this paper
• Response to Influenza A Viral Infection ( COX-1 ) and COX-2 Deficiency on the Host Contrasting Effects of Cyclooxygenase-1

  2005cited by this paper
• Contrasting Effects of Cyclooxygenase-1 (COX-1) and COX-2 Deficiency on the Host Response to Influenza A Viral Infection1

  2005cited by this paper
• Regulation of Found in Inflammatory Zone 1 Expression in Bleomycin-Induced Lung Fibrosis: Role of IL-4/IL-13 and Mediation via STAT-61

  2004cited by this paper
• The Cotton Rat: An Underutilized Animal Model for Human Infectious Diseases Can Now Be Exploited Using Specific Reagents to Cytokines, Chemokines, and Interferons

  2004cited by this paper
• Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis.

  2003cited by this paper
• Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection.

  2003cited by this paper
• Interleukin-4 and Interleukin-13 Signaling Connections Maps

  2003cited by this paper
• Regulation of Lipopolysaccharide Sensitivity by IFN Regulatory Factor-21

  2003cited by this paper
• Alternative activation of macrophages

  2003cited by this paper
• PPARgamma promotes mannose receptor gene expression in murine macrophages and contributes to the induction of this receptor by IL-13.

  2003cited by this paper
• Impaired expression of peroxisome proliferator-activated receptor γ in ulcerative colitis

  2003cited by this paper
• Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways.

  2002cited by this paper
• Cox‐2 Inhibitors: Today and Tomorrow

  2002cited by this paper
• FIZZ1 and Ym as Tools to Discriminate between Differentially Activated Macrophages

  2002cited by this paper
• TH2 Cytokines and Allergic Challenge Induce Ym1 Expression in Macrophages by a STAT6-dependent Mechanism*

  2002cited by this paper
• Involvement of Toll-Like Receptor 4 in Innate Immunity to Respiratory Syncytial Virus

  2001cited by this paper
• Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine.

  2001cited by this paper
• Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus

  2000cited by this paper
• Treatment of Respiratory Syncytial Virus Bronchiolitis and Pneumonia in a Cotton Rat Model with Systemically Administered Monoclonal Antibody (Palivizumab) and Glucocorticosteroid

  2000cited by this paper
• Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells.

  1999cited by this paper
• Pulmonary lesions in primary respiratory syncytial virus infection, reinfection, and vaccine-enhanced disease in the cotton rat (Sigmodon hispidus).

  1999cited by this paper
• Differences in angiogenic potential of classically vs alternatively activated macrophages.

  1997cited by this paper
• Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls.

  1995cited by this paper
• Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation

  1992cited by this paper
• Temporal expression of different pathways of 1-arginine metabolism in healing wounds.

  1990cited by this paper
• The pathogenesis of respiratory syncytial virus infection in cotton rats.

  1978cited by this paper
• Syncytial Virus Infection Il-4 Expression Induced by Respiratory Stat1 Negatively Regulates Lung Basophil Stat1 Negatively Regulates Lung Basophil Il-4 Expression Induced by Respiratory Syncytial Virus Infection Il-4 Contributes to Immunopathology Induced in Mice by Primary Respiratory Syncytial Vir

  year unknowncited by this paper

• Host-pathogen interaction in community-acquired pneumonia: a focus on the immune response.

  2026cites this paper
• Lipoxins as Modulators of Diseases

  2025cites this paper
• Drugs Used in the Treatment of Viral Infections for the Prevention of Airway Remodeling in Asthma

  2025cites this paper
• The immune receptors TLR4 and SLAMF1 regulate TNF release by human metapneumovirus in human macrophages

  2025cites this paper
• Deciphering the Role of Macrophages in RSV Infection and Disease

  2025influential citation
• Assessment of specific IgA and Interferon gamma levels in serum of children with respiratory syncytial virus infection

  2025cites this paper
• Alveolar Macrophages in Viral Respiratory Infections: Sentinels and Saboteurs of Lung Defense

  2025cites this paper
• Preclinical development of the TLR4 antagonist FP12 as a drug lead targeting the HMGB1/MD-2/TLR4 axis in lethal influenza infection

  2025cites this paper
• Unconjugated bilirubin and its derivative ameliorate IMQ-induced psoriasis-like skin inflammation in mice by inhibiting MMP9 and MAPK pathway.

  2024cites this paper
• An adenoviral vector encoding an inflammation-inducible antagonist, HMGB1 Box A, as a novel therapeutic approach to inflammatory diseases

  2024cites this paper
• What have we learned from animal studies of immune responses to respiratory syncytial virus infection?

  2024cites this paper
• Diverging patterns in innate immunity against respiratory viruses during a lifetime: lessons from the young and the old

  2024cites this paper
• Dimethyl ester of bilirubin ameliorates Naja naja snake venom-induced lung toxicity in mice via inhibiting NLRP3 inflammasome and MAPKs activation.

  2024cites this paper
• Short-Chain Fatty Acid (SCFA) as a Connecting Link between Microbiota and Gut-Lung Axis—A Potential Therapeutic Intervention to Improve Lung Health

  2024cites this paper
• The wide spectrum anti-inflammatory activity of andrographolide in comparison to NSAIDs: A promising therapeutic compound against the cytokine storm

  2024cites this paper
• Altered peripheral blood leukocyte subpopulations, function, and gene expression in children with Down Syndrome: Implications for respiratory tract infection.

  2024cites this paper
• Macrophages Orchestrate Airway Inflammation, Remodeling, and Resolution in Asthma

  2023cites this paper
• Airway microbiome-immune crosstalk in chronic obstructive pulmonary disease

  2023cites this paper
• Significance of Pulmonary Endothelial Injury and the Role of Cyclooxygenase-2 and Prostanoid Signaling

  2023cites this paper
• Macrophage Polarization: An Important Candidate Regulator for Lung Diseases

  2023cites this paper
• Immunomodulation of periodontitis with SPMs

  2023cites this paper
• Host Responses to Respiratory Syncytial Virus Infection

  2023cites this paper
• M2a macrophages facilitate resolution of chemically-induced colitis in TLR4-SNP mice

  2023cites this paper
• Respiratory syncytial virus: an overview

  2023cites this paper
• Expression of the readthrough transcript CiDRE in alveolar macrophages boosts SARS-CoV-2 susceptibility and promotes COVID-19 severity.

  2023cites this paper
• Specialized Pro-resolving Lipid Mediators and Resolution of Viral Diseases

  2023cites this paper
• Laminaria japonica Polysaccharide Suppresses Atherosclerosis via Regulating Autophagy-Mediated Macrophage Polarization.

  2022cites this paper
• Inhibition of sPLA2 enzyme activity by cell‐permeable antioxidant EUK‐8 and downregulation of p38, Akt, and p65 signals induced by sPLA2 in inflammatory mouse paw edema model

  2022cites this paper
• Immunity Cell Responses to RSV and the Role of Antiviral Inhibitors: A Systematic Review

  2022influential citation
• M1-like, but not M0- or M2-like, macrophages, reduce RSV infection of primary bronchial epithelial cells in a media-dependent fashion

  2022cites this paper
• Uncovering the core principles of the gut-lung axis to enhance innate immunity in the chicken

  2022cites this paper
• Protection against influenza-induced Acute Lung Injury (ALI) by enhanced induction of M2a macrophages: possible role of PPARγ/RXR ligands in IL-4-induced M2a macrophage differentiation

  2022cites this paper
• The Good and the Bad: Monocytes’ and Macrophages’ Diverse Functions in Inflammation

  2022cites this paper
• Anti-inflammatory and anti-viral actions of anionic pulmonary surfactant phospholipids

  2022cites this paper
• New Insights into the Role of the Complement System in Human Viral Diseases

  2022cites this paper
• Effects of non‐steroidal anti‐inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID‐19

  2022cites this paper
• Regulatory T cells induce polarization of pro-repair macrophages by secreting sFGL2 into the endometriotic milieu

  2021cites this paper
• Role of specialized pro-resolving lipid mediators and their receptors in virus infection: a promising therapeutic strategy for SARS-CoV-2 cytokine storm

  2021cites this paper
• The HIV protease inhibitor Saquinavir attenuates sepsis-induced acute lung injury and promotes M2 macrophage polarization via targeting matrix metalloproteinase-9

  2021cites this paper
• Immunopathology of RSV: An Updated Review

  2021cites this paper
• Aging and Interferons: Impacts on Inflammation and Viral Disease Outcomes

  2021cites this paper
• The effect of carvacrol on respiratory syncytial virus infection in mice model: caution in the use of herbal medicines

  2021cites this paper
• RSV infection-elicited high MMP-12–producing macrophages exacerbate allergic airway inflammation with neutrophil infiltration

  2021cites this paper
• Bias of the Immune Response to Pneumocystis murina Does Not Alter the Ability of Neonatal Mice to Clear the Infection

  2021cites this paper
• MicroRNA-155 and antiviral immune responses.

  2021cites this paper
• Neutrophil extracellular traps (NETs) in a randomized controlled trial of a combination of antiviral and nonsteroidal anti-inflammatory treatment in a bovine model of respiratory syncytial virus infection.

  2021cites this paper
• Recent advances in understanding the role of IL-4 signaling

  2021cites this paper
• Oral administration of Clostridium butyricum rescues streptomycin-exacerbated respiratory syncytial virus-induced lung inflammation in mice

  2021cites this paper
• IL-6-elafin genetically modified macrophages as a lung immunotherapeutic strategy against Pseudomonas aeruginosa infections

  2021cites this paper
• The interplay between airway epithelium and the immune system - A primer for the respiratory clinician.

  2021cites this paper
• Emerging role of nutritional short-chain fatty acids (SCFAs) against cancer via modulation of hematopoiesis

  2021cites this paper
• A Monocyte-Orchestrated IFN-I–to–IL-4 Cytokine Axis Instigates Protumoral Macrophages and Thwarts Poly(I:C) Therapy

  2021cites this paper
• Deficiency of ST2 signaling ameliorates RSV-associated pulmonary hypertension.

  2021cites this paper
• Classical macrophage polarisation is limited by human β-defensin-3 via an autocrine IL-4 dependent process

  2021cites this paper
• PD-1 IC Inhibition Synergistically Improves Influenza A Virus-Mediated Oncolysis of Metastatic Pulmonary Melanoma

  2020cites this paper
• Impact of COVID-19 outbreak in an Italian cohort of patients with systemic sclerosis

  2020cites this paper
• Lytic Cell Death Mechanisms in Human Respiratory Syncytial Virus-Infected Macrophages: Roles of Pyroptosis and Necroptosis

  2020cites this paper
• Use of IL-6-elafin genetically modified regulatory macrophages as an immunotherapeutic against acute bacterial infection in the lung

  2020cites this paper
• Macrophage polarization and its role in the pathogenesis of acute lung injury/acute respiratory distress syndrome

  2020cites this paper
• Promising targets based on pattern recognition receptors for cancer immunotherapy.

  2020cites this paper
• Respiratory syncytial virus infection exacerbates pneumococcal pneumonia via Gas6/Axl-mediated macrophage polarization.

  2020cites this paper
• Interferon-β Plays a Detrimental Role in Experimental Traumatic Brain Injury by Enhancing Neuroinflammation That Drives Chronic Neurodegeneration

  2020cites this paper
• Microbiome dysbiosis in lung cancer: from composition to therapy

  2020cites this paper
• cAMP levels regulate macrophage alternative activation marker expression

  2020cites this paper
• A mouse model of human TLR4 D299G/T399I SNPs reveals mechanisms of altered LPS and pathogen responses

  2020influential citation
• Neutrophils in respiratory syncytial virus infection: From harmful effects to therapeutic opportunities

  2020cites this paper
• Increased phagocytosis in the presence of enhanced M2-like macrophage responses correlates with increased primary and latent HSV-1 infection

  2020cites this paper
• Drupin, a cysteine protease from Ficus drupacea latex accelerates excision wound healing in mice.

  2020cites this paper
• Alveolar Macrophages Treated With Bacillus subtilis Spore Protect Mice Infected With Respiratory Syncytial Virus A2

  2019cites this paper
• Influenza “Trains” the Host for Enhanced Susceptibility to Secondary Bacterial Infection

  2019cites this paper
• C/EBP Homologous Protein (CHOP) Activates Macrophages and Promotes Liver Fibrosis in Schistosoma japonicum-Infected Mice

  2019cites this paper
• Microbes, metabolites, and the gut–lung axis

  2019cites this paper
• Pseudovirus rVSVΔG-ZEBOV-GP Infects Neurons in Retina and CNS, Causing Apoptosis and Neurodegeneration in Neonatal Mice.

  2019influential citation
• Influence of Immunological Maturity on Respiratory Syncytial Virus-Induced Morbidity in Young Children

  2019cites this paper
• Nanoparticle Delivery of RIG-I Agonist Enables Effective and Safe Adjuvant Therapy in Pancreatic Cancer.

  2019cites this paper
• Neonatal Immunity, Respiratory Virus Infections, and the Development of Asthma

  2018influential citation
• Enhanced Replication of Virulent Newcastle Disease Virus in Chicken Macrophages Is due to Polarized Activation of Cells by Inhibition of TLR7

  2018cites this paper
• The Role of Cannabinoid Receptor 1 in the Immunopathology of Respiratory Syncytial Virus

  2018cites this paper
• PKR inhibition mediates endotoxin tolerance in macrophages through inactivation of PI3K/AKT signaling.

  2018cites this paper
• Specialized Proresolving Mediators in Innate and Adaptive Immune Responses in Airway Diseases.

  2018cites this paper
• Regulation of inflammation and angiogenesis in the cornea

  2018cites this paper
• Polarized macrophage subsets differentially express the drug efflux transporters MRP1 and BCRP, resulting in altered HIV production

  2018cites this paper
• Eicosanoid Control Over Antigen Presenting Cells in Asthma

  2018cites this paper
• Molecular and Cellular Response to Experimental Anisakis pegreffii (Nematoda, Anisakidae) Third-Stage Larval Infection in Rats

  2018cites this paper
• Chitinase 3‐like 1 protein plays a critical role in respiratory syncytial virus‐induced airway inflammation

  2018cites this paper
• Dietary Fiber Confers Protection against Flu by Shaping Ly6c− Patrolling Monocyte Hematopoiesis and CD8+ T Cell Metabolism

  2018cites this paper
• Tobacco and Antiretrovirals Modulate Transporter, Metabolic Enzyme, and Antioxidant Enzyme Expression and Function in Polarized Macrophages

  2018cites this paper
• Pneumocystis infection alters the activation state of pulmonary macrophages.

  2017cites this paper
• Pulmonary Susceptibility of Neonates to Respiratory Syncytial Virus Infection: A Problem of Innate Immunity?

  2017cites this paper
• The IL-4 receptor α has a critical role in bone marrow-derived fibroblast activation and renal fibrosis.

  2017cites this paper
• LncRNA MEG3 ameliorates respiratory syncytial virus infection by suppressing TLR4 signaling.

  2017cites this paper
• Macrophages: Their role, activation and polarization in pulmonary diseases

  2017influential citation
• TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection

  2017cites this paper
• Effects of cannabinoid receptor type 2 in respiratory syncytial virus infection in human subjects and mice

  2017cites this paper
• A Mathematical Model for the Macrophage Response to Respiratory Viral Infection in Normal and Asthmatic Conditions

  2017cites this paper
• Exopolysaccharide from Bacillus subtilis Induces Anti-Inflammatory M2 Macrophages That Prevent T Cell–Mediated Disease

  2017cites this paper
• Ross River virus disease clinical presentation, pathogenesis and current therapeutic strategies.

  2017cites this paper
• STAT6 inhibitory peptide given during RSV infection of neonatal mice reduces exacerbated airway responses upon adult reinfection

  2017cites this paper
• Monocytes and Macrophages

  2017cites this paper
• A Role for Neutrophils in Viral Respiratory Disease

  2017cites this paper